• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WEST PHARMA. SERVICES IL WEST PHARMA. SERVICES IL VIAL2BAG DC 13MM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WEST PHARMA. SERVICES IL WEST PHARMA. SERVICES IL VIAL2BAG DC 13MM Back to Search Results
Model Number 6070111
Device Problems Excess Flow or Over-Infusion (1311); Infusion or Flow Problem (2964); Insufficient Information (3190)
Patient Problem No Code Available (3191)
Event Date 08/14/2017
Event Type  Injury  
Event Description
(b)(6), the dop (at (b)(6)) had 4 occurrence reports from labor and deliver of severe and rapid contractions beginning about 10 minutes after oxytocin 20 unit infusion (using v2bdc inline) was started.They reported concerns with increased heart rate of the baby and said they almost had to bring these patients in for emergency c section ((b)(6) thought this morning they may have had to do an emergency c section on one patient).The l/d nursing director noticed that the vial furthest from the bag was not emptying completely and was concerned that the patient was getting an initial bolus of oxytocin when using vial2bag dc inline.The dop assembled it himself and noted that the vial2bagdc 13mm adapter did not fit tightly to the oxytocin 10 unit vial and when attempting to mix the drug into the bag, only the vial closest to the bag was emptying completely but the second vial was maintaining concentrated drug that would not transfer out of the vial, even with adequate air in the bag.The dop described it as a "pressure lock" and said he couldn't transfer anything into or out of the second vial at that point.They stopped using v2bdc with oxytocin after the l/d nursing director came to the dop office this morning and shared her concerns and gave them the details of the adverse event reports.Terry said this was app brand oxytocin.(b)(6) also mentioned that they are having great success with vial2bagdc otherwise but could use additional inservicing in the preop area where he has had repeated leaking reports with cefazolin.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WEST PHARMA. SERVICES IL VIAL2BAG DC 13MM
Type of Device
VIAL2BAG DC 13MM
Manufacturer (Section D)
WEST PHARMA. SERVICES IL
4 hasheizaf street
ra'anana hamerkaz, 43664 11
IS  4366411
MDR Report Key8198202
MDR Text Key131488638
Report Number3000223297-2018-00014
Device Sequence Number1
Product Code LHI
UDI-Device Identifier07290108240061
UDI-Public(01)07290108240061(17)200604(10)9175(90)36098125(91)6070111
Combination Product (y/n)N
PMA/PMN Number
K170095
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Remedial Action Recall
Type of Report Initial,Followup
Report Date 08/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/26/2018
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Expiration Date06/04/2020
Device Model Number6070111
Device Lot Number9175
Was Device Available for Evaluation? No
Date Manufacturer Received08/23/2017
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberRES81877
Patient Sequence Number1
Treatment
OXYTOCIN
Patient Outcome(s) Required Intervention;
-
-